Toggle Nav
Close
  • Menu
  • Setting

Recombinant Mouse IL-4, Tag Free

Catalog No.
PM2005
Recombinant Mouse Interleukin-4(IL-4)without Tag
Grouped product items
SizePriceStock Qty
10ug
$133.00
In stock
100ug
$563.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Interleukin-4 (IL-4) , also known as B cell-stimulatory factor-1, is a monomeric, approximately Th2 cytokine that shows pleiotropic effects during immune responses [1-4]. Mature mouse IL-4 shares 39%, 39%, and 59% aa sequence identity with bovine, human, and rat IL-4, respectively. Human, mouse, and rat IL-4 are species-specific in their activities [5-7]. IL-4 exerts its effects through two receptor complexes [8, 9]. The type I receptor, which is expressed on hematopoietic cells, is a heterodimer of the ligand binding IL-4 R alpha and the common gamma chain. The type II receptor on nonhematopoietic cells consists of IL-4R alpha and IL-13 R alpha 1. The type II receptor also transduces IL-13 mediated signals. IL-4 is primarily expressed by Th2-biased CD4+ T cells, mast cells, basophils, and eosinophils [1, 2]. It promotes cell proliferation, survival, and immunoglobulin class switch to IgG1 and IgE in mouse B cells, acquisition of the Th2 phenotype by naive CD4+ T cells, priming and chemotaxis of mast cells, eosinophils, and basophils, and the proliferation and activation of epithelial cells [10 - 13]. IL-4 plays a dominant role in the development of allergic inflammation and asthma [12, 14]..

Reference

[1]. Benczik, M. and S.L. Gaffen (2004) Immunol. Invest. 33:109.

[2]. Chomarat, P. and J. Banchereau (1998) Int. Rev. Immunol. 17:1.

[3]. Lee, F. et al. (1986) Proc. Natl. Acad. Sci. 83:2061.

[4]. Noma, Y. et al. (1986) Nature 319:640.

[5]. Ramirez, F. et al. (1988) J. Immunol. Meth. 221:141.

[6]. Leitenberg, D. and T.L. Feldbush (1988) Cell. Immunol. 111:451.

[7]. Mosman, T.R. et al. (1987) J. Immunol. 138:1813.

[8]. Mueller, T.D. et al. (2002) Biochim. Biophys. Acta 1592:237.

[9]. Nelms, K. et al. (1999) Annu. Rev. Immunol. 17:701.

[10]. Paludan, S.R. (1998) Scand. J. Immunol. 48:459.

[11]. Corthay, A. (2006) Scand. J. Immunol. 64:93.

[12]. Ryan, J.J. et al. (2007) Crit. Rev. Immunol. 27:15.

[13]. Grone, A. (2002) Vet. Immunol. Immunopathol. 88:1.

[14]. Rosenberg, H.F. et al. (2007) J. Allergy Clin. Immunol. 119:1303.

Description

Accession #

P07750

Alternate Names

B cell growth factor 1; BCDF; BCGF1; BCGF-1; binetrakin; BSF1; BSF-1; IL4; IL-4

Source

Human embryonic kidney cell, HEK293-derived Mouse IL-4 protein

Protein sequence

His23-Ser140

M.Wt

13.4 kDa

Appearance

Solution protein

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

- 12 months from date of receipt, -20 to -70°C as supplied.

Concentration

0. 2 mg/mL

Formulation

Dissolved in sterile PBS buffer.

Reconstitution

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. This solution can be diluted into other aqueous buffers.

Biological Activity

The EC50 for this effect is  0.2-1.0 ng/mL. Measured by its ability to induce IL-11 secretion by Saos-2 human osteosarcoma cells.

Shipping Condition

Shipping with dry ice.

Handling

Centrifuge the vial prior to opening.

Usage

For Research Use Only! Not to be used in humans.

Quality Control

Quality Control & DataSheet

View current batch:
    Purity > 95%, determined by SDS-PAGE.
    Endotoxin: <0.010 EU per 1 ug of the protein by the LAL method.
  • Datasheet